5 insiders reported 24 Form 4 transactions for REVELATION BIOSCIENCES, INC. (REVB) over the past 18 months (most recent 2026-08-18). Recent activity: ROPER JESS (Director) Buy 32,011 shares, Chawla Lakhmir S (Director) Buy 32,011 shares, CARVER JENNIFER (Director) Buy 32,011 shares, Rolke James (Chief Executive Officer) Buy 208,076 shares, Zygmont Chester Stanley III (Chief Financial Officer) Buy 208,073 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | ROPER JESS | Director | Buy | 32,011 | $0 |
| 2026-08-18 | Chawla Lakhmir S | Director | Buy | 32,011 | $0 |
| 2026-08-18 | CARVER JENNIFER | Director | Buy | 32,011 | $0 |
| 2026-08-18 | Rolke James | Chief Executive Officer | Buy | 208,076 | $0 |
| 2026-08-18 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 208,073 | $0 |
| 2026-08-18 | Zygmont Chester Stanley III | Chief Financial Officer | Sell | 208,073 | $0 |
| 2026-08-18 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 208,073 | $0 |
| 2026-05-01 | Zygmont Chester Stanley III | Chief Financial Officer | Sell | 13,285 | $14,614 |
| 2026-05-01 | Rolke James | Chief Executive Officer | Sell | 10,115 | $11,430 |
| 2026-02-05 | CARVER JENNIFER | Director | Sell | 1,661 | $3,106 |
| 2026-02-05 | ROPER JESS | Director | Sell | 1,591 | $2,943 |
| 2026-02-05 | Chawla Lakhmir S | Director | Sell | 2,261 | $4,183 |
| 2026-02-05 | Zygmont Chester Stanley III | Chief Financial Officer | Sell | 13,100 | $21,615 |
| 2026-02-05 | Rolke James | Chief Executive Officer | Sell | 8,521 | $15,849 |
| 2026-01-12 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 78,145 | $70,330 |
| 2026-01-12 | Rolke James | Chief Executive Officer | Buy | 532,829 | $479,546 |
| 2026-01-12 | Chawla Lakhmir S | Director | Buy | 41,981 | $37,783 |
| 2026-01-12 | CARVER JENNIFER | Director | Buy | 41,981 | $37,783 |
| 2026-01-12 | ROPER JESS | Director | Buy | 41,981 | $37,783 |
| 2025-10-31 | Chawla Lakhmir S | Director | Buy | 15,625 | $20,000 |
| 2025-10-31 | CARVER JENNIFER | Director | Buy | 15,625 | $20,000 |
| 2025-10-31 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 390,614 | $499,986 |
| 2025-10-31 | ROPER JESS | Director | Buy | 15,625 | $20,000 |
| 2025-10-31 | Rolke James | Chief Executive Officer | Buy | 390,614 | $499,986 |
Source: SEC Form 4 filings · as of 2026-08-18